Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial-Reference-Cited by-同舟云学术

Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial

Published:2007-01 Issue:1 Volume:132 Page:52-65
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Colombel Jean–Frédéric,Sandborn William J.,Rutgeerts Paul,Enns Robert,Hanauer Stephen B.,Panaccione Remo,Schreiber Stefan,Byczkowski Dan,Li Ju,Kent Jeffrey D.,Pollack Paul F.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference36 articles.

1. Tumor necrosis factor: biology and therapeutic inhibitors;Papadakis;Gastroenterology,2000

2. Tumour necrosis factor and Crohn’s disease;Van Deventer;Gut,1997

3. Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial;Hanauer;Lancet,2002

4. Infliximab for the treatment of fistulas in patients with Crohn’s disease;Present;N Engl J Med,1999

5. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn’s disease;Rutgeerts;Gastroenterology,1999

Cited by 1924 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative real-world outcomes between ustekinumab, infliximab, and adalimumab in bio-naïve and bio-experienced Crohn’s disease patients: a retrospective multicenter study;BMC Gastroenterology;2024-09-11

2. Mortality Trends in Inflammatory Bowel Disease by Age, Sex, and Race in the United States from 1999 to 2020;Inflammatory Bowel Diseases;2024-09-11

3. Malignancy, a real risk in patients using anti-TNF drugs for Crohn’s disease?;Journal of Case Reports and Images in Pathology;2024-08-29

4. Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti-Tumor Necrosis Factors;The Korean Journal of Gastroenterology;2024-08-25

5. Tuberculosis risk in patients with Crohn’s disease on biologics: a retrospective analysis of the Japanese Medical Claims Database;Intestinal Research;2024-08-19